Organerhaltende Therapie beim Peniskarzinom

Arya M, Li R, Pegler K et al (2013) Long-term trends in incidence, survival and mortality of primary penile cancer in England. Cancer Causes Control 24(12):2169–2176

Lont AP, Kroon BK, Horenblas S et al (2006) Presence of high risk human papilllomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer 119(5):1078–1081

Stankiewicz E, Kudahetti SC, Prowse DM et al (2009) HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis. Mod Pathol 22:1160–1168

Chaux A, Netto GJ, Rodríguez IM et al (2013) Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma. World J Urol 31(4):861–867

Backes DM, Kurman RJ, Pimenta JM et al (2009) Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control 20(4):449–457

Alnajjar HM, Lam W, Bolgeri M et al (2012) Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents. Eur Urol 62(5):923–928

Crook J, Grimard L, Pond G et al (2007) Penile brachytherapy: results for 60 patients. Urology 70(3):161–164

Albers P (Hrsg) (2007) Penistumoren, 3.überarbeitete Aufl. Thieme, Stuttgart

Heidenreich A, Pfister D (Hrsg) (2010) Peniskarzinom. Springer, Berlin Heidelberg New York

Ornellas AA, Kinchin EW, Nóbrega BL et al (2008) Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience. J Surg Oncol 97(6):487–495

Protzel C, Alcatraz A, Horenblas S et al (2009) Lymphadenectomy in the surgical management of penile cancer. Eur Urol 55(5):1075–1088

Leijte JA, Kirrander P, Antonini N et al (2008) Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol 54(1):161–168

Djajadiningrat RS, Werkhoven E van, Meinhardt W et al (2014) Penile sparing surgery in penile cancer: does it affect survival? J Urol 191(1):68–73

Minhas S, Kayes O, Hegarty P et al (2005) What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int 96(7):1040–1043

Hakenberg OW, Comperat E, Minhas S et al (2014) Guideline on penile cancer. Eur Urol (im Druck)

Gunia S, Burger M, Hakenberg OW et al (2013) Inherent grading characteristics of individual pathologists contribute to clinically and prognostically relevant interobserver discordance concerning Broders‘ grading of penile squamous cell carcinomas. Urol Int 90(2):207–213

Kakies C, Lopez-Beltran A, Comperat E et al (2014) Reproducibility of histopathologic tumor grading in penile cancer-results of a European project. Virchows Arch 464(4):453–461

Shabbir M, Muneer A, Kalsi J et al (2011) Glans resurfacing for the treatment of carcinoma in situ of the penis: surgical technique and outcomes. Eur Urol 59(1):142–147

Morelli G, Pagni R, Mariani C et al (2009) Glansectomy with split-thickness skin graft for the treatment of penile cancer. Int J Impot Res 21(5):311–314

Gerullis H, Georgas E, Bagner JW et al (2013) Construction of a penoid after penectomy using a transpositioned testicle. Urol Int 90(2):240–242

Zukiwskyj M, Daly P, Chung E (2013) Penile cancer and phallus preservation strategies: a review of current literature. BJU Int 112(Suppl 2):21–26

Hegarty PK, Eardley I, Heidenreich A et al (2014) Penile cancer: organ-sparing techniques. BJU Int 113(1):133–136

Gulino G, Sasso F, Palermo G et al (2013) Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma. Indian J Urol 29(2):119–123

Garaffa G, Raheem AA, Christopher NA, Ralph DJ (2009) Total phallic reconstruction after penile amputation for carcinoma. BJU Int 104(6):852–856